226 related articles for article (PubMed ID: 10611883)
1. Naproxen in the prevention of heterotopic ossification after total hip replacement.
Vielpeau C; Joubert JM; Hulet C
Clin Orthop Relat Res; 1999 Dec; (369):279-88. PubMed ID: 10611883
[TBL] [Abstract][Full Text] [Related]
2. [Eight days of naproxen therapy can prevent heterotopic ossification after total hip alloplasty].
Gebuhr PH; Wilbek H; Soelberg M
Ugeskr Laeger; 1996 Feb; 158(8):1076-8. PubMed ID: 8638341
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of naproxen prophylaxis for the prevention of heterotopic ossification after hip surgery: a meta-analysis.
Ma R; Chen GH; Zhao LJ; Zhai XC
J Orthop Surg Res; 2018 Mar; 13(1):48. PubMed ID: 29506541
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.
Macfarlane RJ; Ng BH; Gamie Z; El Masry MA; Velonis S; Schizas C; Tsiridis E
Expert Opin Pharmacother; 2008 Apr; 9(5):767-86. PubMed ID: 18345954
[TBL] [Abstract][Full Text] [Related]
5. Naproxen prevention of heterotopic ossification after hip arthroplasty. A prospective control study of 55 patients.
Gebuhr P; Soelberg M; Orsnes T; Wilbek H
Acta Orthop Scand; 1991 Jun; 62(3):226-9. PubMed ID: 1904183
[TBL] [Abstract][Full Text] [Related]
6. Indomethacin compared with localized irradiation for the prevention of heterotopic ossification following surgical treatment of acetabular fractures.
Burd TA; Lowry KJ; Anglen JO
J Bone Joint Surg Am; 2001 Dec; 83(12):1783-8. PubMed ID: 11741055
[TBL] [Abstract][Full Text] [Related]
7. Naproxen for 8 days can prevent heterotopic ossification after hip arthroplasty.
Gebuhr P; Wilbek H; Soelberg M
Clin Orthop Relat Res; 1995 May; (314):166-9. PubMed ID: 7634631
[TBL] [Abstract][Full Text] [Related]
8. [Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].
Kölbl O; Flentje M; Eulert J; Barthel T; Knelles D; Kraus U
Strahlenther Onkol; 1997 Dec; 173(12):677-82. PubMed ID: 9454352
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam.
Barthel T; Baumann B; Nöth U; Eulert J
Acta Orthop Scand; 2002 Dec; 73(6):611-4. PubMed ID: 12553505
[TBL] [Abstract][Full Text] [Related]
10. Effect of Naproxen Prophylaxis on Heterotopic Ossification Following Hip Arthroscopy: A Double-Blind Randomized Placebo-Controlled Trial.
Beckmann JT; Wylie JD; Potter MQ; Maak TG; Greene TH; Aoki SK
J Bone Joint Surg Am; 2015 Dec; 97(24):2032-7. PubMed ID: 26677237
[TBL] [Abstract][Full Text] [Related]
11. General short-term indomethacin prophylaxis to prevent heterotopic ossification in total hip arthroplasty.
Hofmann S; Trnka HJ; Metzenroth H; Frank E; Ritschl P; Salzer M
Orthopedics; 1999 Feb; 22(2):207-11. PubMed ID: 10037334
[TBL] [Abstract][Full Text] [Related]
12. No effective prophylaxis of heterotopic ossification with short-term ibuprofen.
Koorevaar CT; Hu HP; Lemmens A; van Kampen A
Arch Orthop Trauma Surg; 1999; 119(3-4):183-5. PubMed ID: 10392515
[TBL] [Abstract][Full Text] [Related]
13. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
[TBL] [Abstract][Full Text] [Related]
14. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial.
Schmidt SA; Kjaersgaard-Andersen P; Pedersen NW; Kristensen SS; Pedersen P; Nielsen JB
J Bone Joint Surg Am; 1988 Jul; 70(6):834-8. PubMed ID: 3134359
[TBL] [Abstract][Full Text] [Related]
15. Prevention of heterotopic ossification by nonsteroid antiinflammatory drugs after total hip arthroplasty.
Sodemann B; Persson PE; Nilsson OS
Clin Orthop Relat Res; 1988 Dec; (237):158-63. PubMed ID: 3142716
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study on the prevention of heterotopic ossification after total hip arthroplasty by Xiaozhong Zhitong].
Liu HP; Li YJ; Wang CX; Li SH; Zhao ZW; Wang JH
Zhongguo Gu Shang; 2011 Oct; 24(10):857-60. PubMed ID: 22097138
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial comparing early postoperative irradiation vs. the use of nonsteroidal antiinflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement.
Kölbl O; Knelles D; Barthel T; Kraus U; Flentje M; Eulert J
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):961-6. PubMed ID: 9392532
[TBL] [Abstract][Full Text] [Related]
18. Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol.
Pakos EE; Pitouli EJ; Tsekeris PG; Papathanasopoulou V; Stafilas K; Xenakis TH
Int Orthop; 2006 Apr; 30(2):79-83. PubMed ID: 16482442
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty.
Legenstein R; Bösch P; Ungersböck A
Arch Orthop Trauma Surg; 2003 Apr; 123(2-3):91-4. PubMed ID: 12664317
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty.
Romanò CL; Duci D; Romanò D; Mazza M; Meani E
J Arthroplasty; 2004 Jan; 19(1):14-8. PubMed ID: 14716644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
